ºÐÀÚÀ¯ÀüÇнÇÇè½Ç (´Ü±¹´ëÇб³ ºÐÀÚ»ý¹°Çаú)



 °ü¸®ÀÚ ( 2015-12-14 21:41:13 , Hit : 1355
 Çѱ¹À¯ÀüÀÚ¼¼Æ÷Ä¡·áÇÐȸ ¼ö»ó¼Ò½Ä


       10th Annual Meeting of Korean Society of Gene and Cell Therapy

       Çѱ¹À¯ÀüÀÚ¼¼Æ÷Ä¡·áÇÐȸ¿¡¼­ Æ÷½ºÅÍ»óÀ» ¼ö»óÇÏ¿´½À´Ï´Ù.

        ÀÌâȣ ¹Ú»ç´ÔÀº 'Pharmacokinetics of a cholesterol-conjugated aptamer targeting
        the hepatitis C virus NS5B protein'À¸·Î
        ÇÑ½Â·Ä ¹Ú»ç´ÔÀº 'Efficient tumor regression through regulated derivatives of
         group 1-based trans-splicing ribozyme'À¸·Î Æ÷½ºÅÍ »óÀ» ¼ö»óÇÏ¿´°í,
         Á¤ÀçÀÎ ÇлýÀº 'Specific delivery of anti-cancer siRNA via CEA aptamer-siRNA  
        chimeras to CEA expression cancer cells'·Î ±¸µÎ¹ßÇ¥¸¦ ÇÏ¿´½À´Ï´Ù.
  
                    ¸ðµÎ ÃàÇϵ帳´Ï´Ù. ^_^







13   ±èÁÖÇö ¹Ú»ç´Ô ³í¹®ÀÌ ¿©·¯ ¸Åü¿¡ ¼Ò°³  °ü¸®ÀÚ 2015/09/08 1528
12   2015³â º¸°ÇÀÇ·á R&D ¿ì¼ö¼º°ú »ç·Ê ¼±Á¤  °ü¸®ÀÚ 2016/01/11 1246
11   À̼º¿í ±³¼ö´Ô ¡®2015³â º¸°ÇÀÇ·á±â¼úÁøÈï À¯°øÀÚ Á¤ºÎÆ÷»ó¡¯ º¹ÁöºÎÀå°ü ǥâ  °ü¸®ÀÚ 2015/12/23 3089
10   Á¶Á¤¼± ¹Ú»ç´Ô ¹Ì·¡ ÀÎÀç»ó ¼ö»ó ¼Ò½ÄÀÔ´Ï´Ù.🏆  °ü¸®ÀÚ 2015/11/10 1285
  Çѱ¹À¯ÀüÀÚ¼¼Æ÷Ä¡·áÇÐȸ ¼ö»ó¼Ò½Ä  °ü¸®ÀÚ 2015/12/14 1355
  ´ëÇпø»ý ¹× ÀÎÅϽ± ¸ðÁý °ø°í  °ü¸®ÀÚ  2016/10/14 1424
7   hTERT T/S ribozyme ±â¼ú ¼Ò°³ ('Lab'¿¡¼­ '½ÃÀå'À¸·Î ³ª¿Â ½Å¾à°³¹ß±â¼úµé-¹ÙÀÌ¿À½ºÆåÅ×ÀÌÅÍ)  °ü¸®ÀÚ 2016/11/08 1673
  ´ëÇпø»ý ¹× ÀÎÅϽ± ¸ðÁý °ø°í  °ü¸®ÀÚ  2017/01/02 1510
5   2016³â Çѱ¹À¯ÀüÀÚ¼¼Æ÷Ä¡·áÇÐȸ (KSGCT) Çмú´ëȸ ¿ì¼öÆ÷½ºÅÍ»ó ¼ö»ó  °ü¸®ÀÚ 2017/02/06 1118
4   ±è¼ºÁø ¹Ú»ç ³í¹® ¿©·¯ ¸Åü¿¡ ¼Ò°³ (Molecular Therapy- KRAS ribozyme)  °ü¸®ÀÚ 2017/02/16 3540
3   ºÐÀÚÀ¯ÀüÇÐ ½ÇÇè½Ç¿¡ »õ·Î¿î ¹Ú»ç´ÔÀÌ Åº»ýÇÏ¿´½À´Ï´Ù~!  °ü¸®ÀÚ 2018/02/22 1747
2   ÃÖ±Ù ÀÛ¼ºÇÑ ¸®ºä³í¹® 'Advanced Science News'¿¡ ¼Ò°³  °ü¸®ÀÚ 2018/02/23 1685
1   Molecular Med TRI-CON 2018 ±¸µÎ°­¿¬  °ü¸®ÀÚ 2018/02/23 1616

[1][2][3][4][5] 6
 

Copyright 1999-2023 Zeroboard / skin by ROBIN